*Cellular and Molecular Gastroenterology and Hepatology* (*CMGH*), like all American Gastroenterological Association (AGA) journals, is run by a team of editors drawn from academia. We have laboratories, we publish articles, and we care about authors' experiences---our own, and those at *CMGH*. We are acutely aware of the importance of metrics such as the impact factor, whether we agree with them or not. So why should authors submit to *CMGH* when our first impact factor is several years away?

All new journals have a 3-year waiting period before receiving an impact factor and other metrics from Thompson-Reuters (ISI). We at *CMGH* have mixed feelings about this. The Board of Editors, along with an increasing number of scientists, believes that impact factors fail to accurately reflect the quality of either journals or individual articles. As such, no research paper submitted to *CMGH* so far has been accepted or rejected based on its potential to influence our future impact factor, and it is our goal that the impact factor will never play a role in a decision. Nonetheless, we appreciate that impact factors wield considerable influence over journal submissions and readership, and that they play a significant role in promotion decisions for many authors. We are committed to maximizing the impact of *CMGH*, both through the commissioning of exciting reviews and through multiple means of drawing attention to the research articles.

All *CMGH* articles are indexed by Google Scholar, and we have applied for early indexing in PubMed; we hope that the journal will be fully searchable in PubMed by early 2016. It is worth noting that *all National Institutes of Health-funded work* published in *CMGH* is already searchable in PubMed.

We continue to work actively with the AGA and our publisher Elsevier to publicize *CMGH* and individual articles. We send out at least two press releases per issue, and we work with university communications offices to publicize the work of their authors. We are gaining traction in the media; in general, *CMGH* articles are performing above average in terms of media views, and they have received coverage from a variety of news outlets including *Medical Xpress*, *HCP Live*, *Science Daily*, *NewsMedical*, *Medscape*, *Hepatitis News Today*, and *Science World Report*. A significant percentage of research articles are highlighted through editorials, and we have three covers per issue, thus maximizing article impact.

*CMGH* has a vigorous presence on social media. More than a thousand Facebook friends now receive frequent illustrated updates on new articles published. *CMGH* also publicizes articles via Twitter and other social media. Altmetric, available through the journal Web site, enables authors to see the attention their specific articles are receiving in the news and through social media ("article-level metrics"). A link on the *CMGH* home page connects to our top-rated articles (<http://www.journals.elsevier.com/cellular-and-molecular-gastroenterology-and-hepatology/altmetric-articles/>). Access to the journal is free, with no subscription fees, and we encourage readers throughout the world to download articles and figures. Although *CMGH* is an online journal, we have and will continue to print "mini-issues" for free distribution at Digestive Disease Week.

As part of our commitment to authors, *CMGH* aims for rapid review and online availability. Our time from submission to an initial decision averages less than 3 weeks, and accepted articles are online, searchable, and promotable (ie, the embargo is lifted) within several days of acceptance. The Board of Editors has weekly teleconferences and prioritizes consistency in decisions. We have opted to publish online issues of *CMGH* every other month to maintain the quality of the articles---our goal is to publish the best rather than the most research in GI. Our word limits are generous, and there are no constraints on the number or format of figures; we provide authors with the ability to publish their work in complete form, as they believe it should be published. Our publication fees are reasonable, and can be waived in case of financial hardship.

Finally, keep an eye on *CMGH* for new features designed to enhance the readability and readership of the journal. We have a fantastic professional medical illustrator who illustrates all reviews; she will soon be contributing animated figures to some of the research articles. In acknowledgment of the broad nature of the gastrointestinal research community, we will shortly add a regular column addressing research issues of interest to diverse groups of scientists, including senior researchers, postdoctoral fellows, researchers at primarily undergraduate institutions, and international scientists.

As we publish the final issue of our first year, we at *CMGH* are increasingly enthusiastic about the journal. We look forward to continuing to be a journal "by scientists and for scientists" and, as always, appreciate your input and suggestions.
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